68Ga-PSMA-PET/CT在前列腺癌盆腔放疗淋巴结覆盖范围定义中的作用
该回顾性研究分析138例初诊前列腺癌患者的68Ga-PSMA-PET/CT图像,共识别441个阳性淋巴结转移灶。研究发现,将盆腔野上界从L5/S1延伸至L4/L5可使淋巴结覆盖准确率提高约20%,提示近端髂总淋巴结照射的重要性,尤其在多发淋巴结转移患者中。
要点
- 盆腔野上界延伸至L4/L5可提高约20%患者的淋巴结覆盖准确率。
- 髂内淋巴结是最常见的转移部位,占25.2%。
- 多发淋巴结转移是盆腔野外淋巴结的预测因素。
核心结论
- 将盆腔野颅侧边界从L5/S1延伸至L4/L5可使约20%患者的盆腔照射准确率提高,凸显近端髂总淋巴结照射的重要性,尤其在多发淋巴结转移患者中。
研究设计与样本
- 回顾性分析138例初诊前列腺癌患者的68Ga-PSMA-PET/CT图像,将阳性淋巴结与单一计划CT配准,评估三种盆腔体积的淋巴结覆盖情况。
主要发现
- 共识别441个PSMA-PET阳性淋巴结转移灶,最常见为髂内淋巴结(25.2%)。
- 盆腔野外腹主动脉旁和骶前淋巴结分别见于20例(14.5%)和22例(15.9%)患者。
- 整个队列中GETUG试验、RTOG指南和上界延伸至L4/L5的盆腔野淋巴结覆盖 rate 分别为44.2%、52.2%和71%。
- 仅盆腔淋巴结转移患者中上述三种盆腔野覆盖率分别为51.7%、61%和83.1%。
- 转移淋巴结数量是盆腔野外淋巴结的预测因素。
关键数值与推荐
- GETUG试验盆腔野淋巴结覆盖率为44.2%(整个队列)和51.7%(仅盆腔淋巴结转移患者)。
- RTOG指南盆腔野淋巴结覆盖率为52.2%(整个队列)和61%(仅盆腔淋巴结转移患者)。
- 上界延伸至L4/L5的盆腔野覆盖率为71%(整个队列)和83.1%(仅盆腔淋巴结转移患者)。
临床怎么用
- 对于前列腺癌盆腔放疗,考虑将盆腔野上界延伸至L4/L5以覆盖近端髂总淋巴结,尤其对多发淋巴结转移患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the distribution of metastatic lymph nodes (LN) detected on 68Ga-PSMA-positron emission tomography/computed tomography (PET/CT) in treatment-naïve prostate cancer (PC) patients and to analyze the LN coverage rates of the pelvic fields defined in the GETUG trial and RTOG guidelines and a pelvic field extending superiorly from the L4/L5 interspace. MATERIALS AND METHODS: 68Ga-PSMA-PET/CT images obtained at diagnosis of 138 PC patients were retrospectively analyzed. The number and locations of 68Ga-PSMA-positive LNs were co-registered with one single-planning CT. The numbers, locations, and sizes of LNs located outside the three pelvic volumes were investigated for the entire cohort and for patients with LN metastasis in the pelvic area only. RESULTS: A total of 441 PSMA-PET-positive LN metastases were identified. The most frequent metastatic LNs were internal iliac LNs (25.2%). Para-aortic and presacral LNs outside the three pelvic fields were present in 20 (14.5%) and 22 patients (15.9%), respectively. The LN coverage rates according to the GETUG trial, the RTOG guidelines, and the pelvic field extending superiorly from L4/L5 were 44.2%, 52.2%, and 71, respectively, in the entire cohort and 51.7%, 61 and 83.1%, respectively, in patients with only pelvic LN metastasis. The number of metastatic LNs was a predictive factor for LNs located outside the three pelvic fields. CONCLUSIONS: Extending the cranial margin of the pelvic field from L5/S1 to L4/L5 increases the accuracy of pelvic field irradiation in approximately 20% of patients, highlighting the importance of proximal common iliac irradiation, particularly in patients with multiple LN metastasis.
引用
- Onal C, Ozyigit G, Guler OC, et al. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients. Radiother Oncol. 2020. PMID: 32861704. doi:10.1016/j.radonc.2020.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。